Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: Results from a prospective, randomized study

Thyroid

Volumn 8, Issue 8, 1998, Pages 653-659

  Ljunggren, Jan Gustaf ^a   Törring, Ove ^a   Wallin, Göran ^a   Taube, Adam ^b   Tallstedt, Leif ^c   Hamberger, Bertil ^a   Lundell, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; THYROIDECTOMY;

EID: 0031783483     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.653     Document Type: Article

References (15)

1. Glinoer D, Hesch D, Lagasse R, Laurberg P 1987 The management of hyperthyroidism due to Graves' disease in Europe 1986. Results of an international survey. Acta Endocrinol (Copenh) 285(Suppl):5-23.
2. Solomon B, Glinoer D, Lagasse R, Wartofsky L 1990 Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70:1518-1524.
3. Wartofsky L, Glinoer D, Solomon B, Lagasse R 1991 Differences and similarities in the treatment of diffuse goiter in Europe and the United States. Exp Clin Endocrinol 97:243-251.
4. Ford HC, Delahunt JW, Peek CM 1991 The management of Graves' disease in New Zealand: results of a national survey. N Z Med J 104:251-252.
5. Nagayama Y, Izumi M, Nagataki S 1989 The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association. Endocrinol Jpn 36:299-314.
6. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R 1991 Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan and the United States. Thyroid 1:129-135.
7. Wartofsky L 1993 Has the use of antithyroid drugs for Graves' disease become obsolete? Thyroid 3:335-344.
8. Franklyn JA 1994 The management of hyperthyroidism. N Engl J Med 330:1731-1738.
9. Menegaux F, Ruprecht T, Chigol JP 1993 The surgical treatment of Graves' disease. Surg Gynecol Obstet 176:277-282.
10. Holm LE, Lundell G, Israelsson A, Dahlqvist I 1982 Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med 23:103-107.
11. Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A, Larsson LG, Lidberg M, Lindberg S, Tennvall J, Wicklund H, Boice JD Jr 1991 Cancer risks after iodine-131 therapy for hyperthyroidism. J of the National Cancer Institute 83:1072-1077.
12. Hall P, Boice Jr JD, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Mattsson A, Tennvall J, Wiklund K, Holm L-E 1992 Leukemia incidence after iodine-131 exposure. Lancet 340:1-4.
13. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130:494-497.
14. Törring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Sääf M, Hamberger B, The Thyroid Study Group 1996 Graves' Hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine - A prospective, randomised study. J Clin Endocrinol Metab 81:2986-2993.
15. Tallstedt L, Lundell G, Törring O, Wallin G, Ljunggren JG, Blomgren H, Taube A, The Thyroid Study Group 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.